Gene: ADAMTS16
Official Full Name: ADAM metallopeptidase with thrombospondin type 1 motif 16provided by HGNC
Gene Summary: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may inhibit chondrosarcoma cell proliferation and migration. This gene may regulate blood pressure. [provided by RefSeq, May 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20003 | ADAMTS16 Knockout cell line (HeLa) | Human | ADAMTS16 | 1:3~1:6 | Negative | Online Inquiry |
KO20004 | ADAMTS16 Knockout cell line (HEK293) | Human | ADAMTS16 | 1:3~1:6 | Negative | Online Inquiry |
ADAMTS16 Gene Knockout Cell Lines are specialized cellular models engineered to disrupt the ADAMTS16 gene, which encodes a member of the A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) family. These cells serve as powerful tools for investigating the functional roles of ADAMTS16 in various biological processes, including cell signaling, extracellular matrix remodeling, and tissue homeostasis.
The primary function of the ADAMTS16 gene knockout cell lines is to facilitate research into the consequences of ADAMTS16 deficiency in cellular contexts, enabling the elucidation of its role in pathology. The knockout mechanism is achieved through targeted gene editing techniques, such as CRISPR-Cas9, ensuring a precise alteration of the genetic material. As a result, researchers can study the phenotypic and molecular changes associated with the absence of this gene, shedding light on its contribution to diseases such as osteoarthritis, where the regulation of matrix metalloproteinases is critical.
In terms of scientific importance, these knockout cell lines are invaluable in both basic and applied research settings. They provide a robust platform for drug discovery, as understanding the ADAMTS16 pathway opens avenues for therapeutic intervention. Furthermore, in clinical applications, these models can aid in the identification of biomarkers for disease progression and response to treatments.
What sets our ADAMTS16 Gene Knockout Cell Lines apart from conventional models is their validated genetic alteration and extensive characterization. This ensures reproducibility and reliability in experimental outcomes, reducing the uncertainty often associated with less rigorously validated models. Moreover, our cell lines come with comprehensive usage protocols and support, streamlining the integration into existing research projects.
For researchers and clinicians alike, leveraging ADAMTS16 Gene Knockout Cell Lines provides a unique opportunity to uncover fundamental insights into the molecular underpinnings of disease, making it an indispensable tool in the pursuit of innovative therapeutic strategies. Our company prides itself on expertise in genetic engineering and commitment to advancing research through high-quality biological products, ensuring that our customers have the best tools at their disposal to drive discoveries forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.